|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 134.17 USD | -0.08% |
|
-0.02% | +77.76% |
| 07-08 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| 06-25 | Major deals involving US drugmakers and biotechs over the past decade | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 134.29 | 134.29 | 134.28 |
| Spread/Res. | -0.09% | -0.09% | -0.08% |
| Spread/Supp. | +25.40% | +47.60% | +96.07% |
| Support | 106.99 | 90.9 | 68.43 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- APGE Stock
- Charts Apogee Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
